Proscia Expands AI Capabilities to Support Skin Pathology Evaluation
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology’s most diverse specialties.
Read MorePosted by Edisource Vendor | Oct 15, 2025 | Melanoma |
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology’s most diverse specialties.
Read MorePosted by Edisource Vendor | Oct 14, 2025 | Biochemicals & Chemical Reagents |
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
Read MorePosted by Edisource Vendor | Oct 14, 2025 | Controls |
The quality control product now includes eight opioid drugs or drug metabolites at concentrations above and below assay cutoffs.
Read MorePosted by Edisource Vendor | Oct 10, 2025 | Molecular Diagnostic Analyzers |
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MorePosted by Edisource Vendor | Oct 10, 2025 | Cancer |
OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.
Read More